Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Current Leases (2021 - 2023)

AVITA Medical posted quarterly Current Leases of $895000.0 for Q4 2023, up 46.24% year-on-year from $612000.0 in Q4 2022, and up 46.24% on a QoQ basis from $612000.0 in Q4 2022.

AVITA Medical (RCEL) has 3 years of Current Leases data on file, last reported at $895000.0 in Q4 2023.

  • For the quarter ending Q4 2023, Current Leases rose 46.24% year-over-year to $895000.0; the trailing twelve-month figure through Dec 2023 stood at $895000.0 (up 46.24% YoY), and the FY2023 full-year result was $895000.0, up 46.24% from the prior year.
  • Current Leases for Q4 2023 stood at $895000.0, up from $612000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $895000.0 in Q4 2023 and bottomed at $612000.0 in Q4 2022.
  • The 3-year median for Current Leases is $702000.0 (2021), against an average of $726200.0.
  • The widest annual swing landed in 2022, when Current Leases decreased 15.0%; it then jumped 46.24% in 2023.
  • A 3-year view of Current Leases shows it stood at $720000.0 in 2021, then retreated by 15.0% to $612000.0 in 2022, then surged by 46.24% to $895000.0 in 2023.
  • The last three Current Leases figures came in at $895000.0 (Q4 2023), $612000.0 (Q4 2022), and $702000.0 (Q3 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 24.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 20.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 35.80 Mn
10 AVITA Medical 121.89 Mn 103.71 Mn 14.31 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 895,000.00
Dec 31, 2022 612,000.00
Sep 30, 2022 702,000.00
Dec 31, 2021 720,000.00
Jun 30, 2021 702,000.00